Literature DB >> 23960610

After more than 300 defibrillation shocks, patient still alive 12 years later refractory torsade de pointes due to polypharmacy and persistent vomiting.

Akhtar Hussain1, Sami Ghazal.   

Abstract

Acquired torsade de pointes ventricular tachycardia (TdP) is a rare but serious life-threatening arrhythmia caused by an array of cardiac and non-cardiac drugs. It is often refractory to pharmacological therapy and may result in death or require frequent defibrillations. In our case study a young female patient with no underlying heart disease developed very frequent sustained TdP requiring frequent defibrillations without which she would have certainly died. The ventricular arrhythmia in this patient was of multifactorial origin - cisapride, drug-drug interaction and persistent vomiting resulting in electrolyte disturbance and malnutrition. The patient survived after more than 300 defibrillation shocks over a period of 5 days and she is still alive 12 years later.

Entities:  

Keywords:  Arrhythmia; Bulimia; Cisapride; QT interval; Torsade

Year:  2010        PMID: 23960610      PMCID: PMC3727540          DOI: 10.1016/j.jsha.2010.04.007

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  9 in total

Review 1.  Clinical and therapeutic aspects of congenital and acquired long QT syndrome.

Authors:  Ijaz A Khan
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

2.  Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.

Authors:  D K Wysowski; A Corken; H Gallo-Torres; L Talarico; E M Rodriguez
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

3.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

5.  Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.

Authors:  José M Di Diego; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

6.  Electrolyte and other physiological abnormalities in patients with bulimia.

Authors:  J E Mitchell; R L Pyle; E D Eckert; D Hatsukami; R Lentz
Journal:  Psychol Med       Date:  1983-05       Impact factor: 7.723

Review 7.  Drug therapy for torsade de pointes.

Authors:  S Banai; D Tzivoni
Journal:  J Cardiovasc Electrophysiol       Date:  1993-04

Review 8.  Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.

Authors:  Akshay Gupta; Andrew T Lawrence; Kousik Krishnan; Clifford J Kavinsky; Richard G Trohman
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

9.  QT interval and QT dispersion in eating disorders.

Authors:  Yoshiyuki Takimoto; Kazuhiro Yoshiuchi; Hiroaki Kumano; Gaku Yamanaka; Tadashi Sasaki; Hiroyuki Suematsu; Yuzo Nagakawa; Tomifusa Kuboki
Journal:  Psychother Psychosom       Date:  2004 Sep-Oct       Impact factor: 17.659

  9 in total
  1 in total

1.  Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates.

Authors:  Sebastian Polak; Michael K Pugsley; Norman Stockbridge; Christine Garnett; Barbara Wiśniowska
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.